Focus of Trial | Domains and Subdomains Endorsed* |
---|---|
All trials | Endorsed by both patients and physicians: activity, damage, death, function, patient’s global assessment, physician’s global assessment, quality of life, remission, work productivity |
Endorsed by patients only: no. papulopustular lesions, pain of nodular lesions | |
Mucocutaneous disease | Endorsed by both patients and physicians: duration of oral ulcers, duration of genital ulcers, duration of nodular lesions, new organ involvement, no. oral ulcers, no. genital ulcers, pain of genital ulcers, pain of oral ulcers |
Endorsed by patients only: no. papulopustular lesions, pain of nodular lesions | |
Ocular disease | Endorsed by both patients and physicians: blurry vision, cystoid macula edema, ocular attack, retinal vasculitis, visual acuity |
Endorsed by patients only: duration of ocular attack, glucocorticoid tapering | |
Vascular disease | Endorsed by both patients and physicians: disease-related damage, extended venous thrombus, hemoptysis, new aneurysm, new arterial thrombus, new venous thrombus, post-thrombotic syndrome |
Endorsed by patients only: shortness of breath | |
Neurologic disease | Endorsed by both patients and physicians: cognitive functioning, headache, progression on magnetic resonance imaging |
Endorsed by patients only: disease-related damage, dizziness, neuropathic pain, neuropathy | |
Gastrointestinal disease | Endorsed by both patients and physicians: abdominal pain, clinical remission, diarrhea, endoscopic remission |
Endorsed by patients only: nausea, disease-related damage, weight loss | |
Joint disease | Endorsed by both patients and physicians: duration of arthritis episodes, no. arthritis episodes, physical function, swollen joint count, tender joint count |
↵* Results based on responses by 56 patients and 74 physicians.